from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3807c/-

LFCtreatmentdescriptionclass of inhibitor

-0.702

Amikacinug/mL Amikacintranslation

-2.473

Cap5-10ug/mL Capreomycintranslation

-3.000

Rox10-50 ug/mL Roxithromycintranslation

-0.165

SM2-5 ug/mL Streptomycintranslation

-1.485

Tet5-10 ug/mL Tetracyclinetranslation

0.333

Rif0.2-5ug/mL Rifampicintranscription

-0.034

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.242

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.802

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.269

CPZ10-50 ug/mL Chlorpromazinerespiration

0.094

Clofazimine10-13 ug/mL Clofaziminerespiration

0.470

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.916

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.304

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.844

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.117

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.237

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.053

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.263

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.230

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.062

KCN5-20 ug/mL Potassium cyaniderespiration

0.842

NaN30.2-2 mM Sodium aziderespiration

0.806

Nigericin50 uM Nigericinrespiration

-0.588

TRC10-150 ug/mL Triclosanrespiration

-1.382

TRZ10-25 ug/mL Thioridazinerespiration

-0.614

Valinomycin0.5-10 uM Valinomycinrespiration

0.519

ZnSO42 mM ZnSO4respiration

-0.607

menadione6-10 ug/mL Menadionerespiration

0.197

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.072

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.002

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.642

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.081

NRP_1Non-replicating persistence stage 1dosRassociated

0.578

Amp0.2mg/mL AmpicillincellWall

0.761

Cephalexin20-100 ug/mL CephalexincellWall

0.358

Cerulenin0.32-5 ug/mL CerulenincellWall

0.094

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.607

EMB10-20 ug/mL EthambutolcellWall

0.552

Eta12-40 ug/mL EthionamidecellWall

1.150

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.063

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.115

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.599

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.490

BZA0.12 mg/mL BenzamidearomaticAmides

0.186

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.663

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.303

H2O24 mM hydrogen peroxideDNAdamaging

0.334

Levo10 ug/mL LevofloxacinDNAdamaging

-0.041

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.015

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.367

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.112

UVUV-irradiationDNAdamaging

-0.948

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.091

Antimycin12.5-50 ug/mL Antimycin A?

0.367

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.116

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.116

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.951

PA8240.2-2 ug/mL PA-824?

0.139

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.809

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.537

Verapamil50 uM Verapamil?

0.615

mercaptoethanol2 mM 2-Mercaptoethanol?

0.521

methoxatin10-20 ug/mL Methoxatin?